Pediatric Infectious Diseases and Pharmacology for Primary Care

Pediatric Infectious Diseases and Pharmacology for Primary Care is organized by MCE Conferences, Inc. and will be held from Jun 27 - 29, 2025 at Hotel Effie Sandestin, Autograph Collection, Miramar Beach, Florida, United States of America.

Description:
This conference is designed to provide primary care practitioners with up-to-date, evidence-based information on commonly encountered issues in Pediatric Infectious Diseases and Pharmacology while suggesting pragmatic approaches to clinical management. The discussion-based format of the conference will encourage audience participation through dynamic lectures, case-based studies, and hands-on workshops. Keynote speakers will present and critically assess recent advancements and industry updates in Pediatric Infectious Diseases and Pharmacology with the goal of enhancing the knowledge-base and core competence of attendees. The successful completion of this interactive program diagnosing, treating, and prescribing the most effective courses of treatment, with the ultimate goal of improving patient outcomes.

Best Practices in Prescribing Opioids: A Regulatory Perspective
Objectives:

1) Describe evolving opioid prescribing and regulatory practices in the United States
2) Discuss recently released opioid prescribing guidelines, while highlighting the relevance to primary care providers?
3) Determine best practices for managing patients with chronic nonmalignant pain, while highlighting guidance from a regulatory perspective 
4) Discuss cases, investigations, and licensure outcomes involving prescribers and opioids to identify practice improvement opportunities

Medical Management of Common Substance Use Disorders
Objectives: 

1) Explore evidence-based treatment approaches for substance use disorders 
2) Discuss strategies to fully engage patients and their families in the process, including shared decision-making and building trust 
3) Gain insights into pharmacotherapeutic treatments, including their mechanisms of action, risks, and benefits as well as relevant psychosocial and psychotherapeutic interventions

Pain in the Neck: Approach to Children with Lymphadenopathy
Objectives: 

1) Recognize the common causes of lymphadenopathy in children 
2) Plan a management course for common causes of adenopathy 

What’s New in Pneumonia?
Objectives:

1) Identify optimal antibiotic choices for pneumonia in the office setting 
2) Plan an optimal length of antibiotic therapy 

Herpes are Like Diamonds, They’re Forever
Objectives: 

1) Recognize the common presentations, diagnosis, and management of EBV and HSV in children? 

Addressing Vaccine Hesitancy: What Works, What Doesn’t?
Objectives: 

1) Identify novel strategies to discuss vaccine skepticism in the office setting 
2) Discuss how we maintain vaccine safety systems in the USA

What’s All the Pus About? Staphylococcal and Streptococcal Infections
Objectives: 

1) Plan appropriate management strategies for skin and soft tissue infections, due to S. aureus and S. pyogenes 
2) Identify suppurative and nonsuppurative complications of streptococcal infections 
3) Plan appropriate therapy for recurrent skin and soft tissue infections 

Field Notes: Recent Cases from Pediatric Infectious Diseases
Objectives: 

1) Hone the ability to build differential diagnoses for acute infectious processes 
2) Identify common and uncommon causes of infectious disease syndromes 
3) Recognize characteristics of new emerging infections, such as monkeypox 

Pharmacotherapy and Mood Stabilizers in Primary Care: Considerations for “Off-Label” Prescribing
Objectives: 

1) Discuss “off-label” use of mood stabilizers and psychotropic agents for agitation, restlessness, insomnia, and other behavioral symptoms 
2) Differentiate commonly prescribed agents by pharmacologic class, mechanism of action, pharmacokinetic factors, indications and uses, tolerability, and efficacy 
3) Apply best practices in prescribing and shared decision-making when considering “off label” use of drugs in a case scenario involving dementia and brain injury 
4) Consider steps to optimize benefits and reduce risks to patients, while prescribing with liability authority

Drug Therapy for the Prevention and Treatment of Osteoporosis
Objectives: 

1) Define treatment goals for patients with or at-risk for osteoporosis 
2) Relate treatment strategies to empiric evidence regarding fracture prevention and treatment for women and men 
3) Develop a prevention and monitoring plan for patients at-risk for osteoporosis 
4) Describe pertinent pharmacologic parameters related to pharmaceuticals used in the prevention and treatment of osteoporosis

Managing Anxiety and Sleep Disorders: Drug and Non-Pharmacologic Considerations ?
Objectives: 

1) Describe signs and symptoms of common sleep disorders and anxiety disorders with a focus on older adults. 
2) Discuss common anxiety disorders, including the neurobiological basis of disease, clinical presentation, assessment, and approach to treatment. 
3) Recognize evidence-based treatments for insomnia and common anxiety disorders, including lifestyle, behavioral, and pharmacologic interventions. 
4) Identify key parameters that warrant referral to specialty care for individuals with insomnia and/or anxiety disorders

Optimizing Psychopharmacotherapy in Depression: Clinical Cases
Objectives: 

1) Discuss pharmacologic management options within clinical cases of patients withdepression
2) Relate physiologic and pathophysiologic alterations of brain neurochemistry to symptoms of depression, including the genetic link and molecular basis of injury 
3) Apply clinical practice guidelines for antidepressant therapies 
4) Identify key parameters for medications used to treat mechanism, safety, tolerability, efficacy, cost, and simplicity of use

Rules of Immunity: Considering Primary Immunodeficiencies in the Outpatient Setting
Objectives: 

1) Identify the most common causes of primary immunodeficiency in children 
2) Recognize the most common ‘red flags’ for consideration of immune deficiency? 

History is Everything: Evaluation of Fever of Unknown Origin
Objectives: 

1) Develop a systematic evaluation of children with FUO 
2) Identify patterns seen in commonly diagnosed infectious causes of FUO